$0.35
-0.03 (-8.32%)
Open$0.37
Previous Close$0.38
Day High$0.38
Day Low$0.34
52W High$19.11
52W Low$0.34
Volume—
Avg Volume7.05M
Market Cap29.03M
P/E Ratio—
EPS$-3.74
SectorPharmaceuticals
Analyst Ratings
Buy
19 analysts
Price Target
+2,543.5% upside
Current
$0.35
$0.35
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.69M | 39.15M | 211.34M |
| Net Income | -263,879,002 | -260,492,598 | 52.60M |
| Profit Margin | -739.4% | -702.5% | 24.9% |
| EBITDA | -274,303,501 | -285,826,835 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | -8.8% | -8.8% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |